Anthracyclines News and Research

RSS
FOXM1 contributes to treatment failure in acute myeloid leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

New discovery could pave way for improved leukemia treatment

New discovery could pave way for improved leukemia treatment

Combating cardiac complications caused by cancer treatment

Combating cardiac complications caused by cancer treatment

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

Breast cancer patients may be at increased risk of cardiovascular diseases

Breast cancer patients may be at increased risk of cardiovascular diseases

Adults that survived childhood cancer are at risk of developing hypertension, study reveals

Adults that survived childhood cancer are at risk of developing hypertension, study reveals

Childhood cancer survivors more likely to have high blood pressure as adults

Childhood cancer survivors more likely to have high blood pressure as adults

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes may reduce effectiveness of chemotherapeutic drug

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

Women undergoing breast cancer treatment are not getting recommended follow-up heart scans

Women undergoing breast cancer treatment are not getting recommended follow-up heart scans

DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

AKR1C3 enzyme could be promising therapeutic target for managing CRPC, AML

AKR1C3 enzyme could be promising therapeutic target for managing CRPC, AML

Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

MedUni Vienna researchers identify reason for chemoresistance in small cell lung cancer

MedUni Vienna researchers identify reason for chemoresistance in small cell lung cancer

PharmaMar begins PM184 Phase II trial in advanced breast cancer patients

PharmaMar begins PM184 Phase II trial in advanced breast cancer patients

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Study sheds light on clinical and biological characteristics of male breast cancer

Study sheds light on clinical and biological characteristics of male breast cancer

Combination therapy benefits patients with acute myeloid leukemia

Combination therapy benefits patients with acute myeloid leukemia